Skip to content

A randomised controlled trial of group psychoeducation with bipolar affective disorder patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN82941238
Enrollment
70
Registered
2005-09-30
Start date
2003-12-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders: Bipolar disorders Mental and Behavioural Disorders Bipolar disorders

Interventions

Randomised controlled trial, research with outpatients

Sponsors

Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 70 bipolar patients from Newcastle and North Tyneside.

Exclusion criteria

Exclusion criteria: 1. Patient with learning disability, axis 1 co-morbidity, alcohol or drug dependency 2. Serious suicidal intent 3. Personality disorder 4. Organic brain disorder 5. Patients undergoing any concurrent psychological therapy 6. Bipolar disorder with a seasonal pattern

Design outcomes

Primary

MeasureTime frame
1. Time to manic relapse and number of manic relapses in each 6 month period. Relapse will be defined as SCID criteria for hypomania or mania. Raters (who will be blind to the randomisation) will keep in close contact with patients, keyworkers and RMOs to ensure that relapses are spotted. 2. Social functioning determined by standardised ratings at 0, 6, 12, and 18 months after randomisation. 3. MADRS and Young scores will be determined at 0, 6, 12 and 18 months after randomisation.

Secondary

MeasureTime frame
In order to provide clarification of how patients have progressed throughout the course of the study patients in both conditions will be keeping a mood diary on a daily basis. The mood diary lists a variety of symptoms associated with bipolar disorder. Each day patients will rate the severity of each of the symptoms on a 4 point scale (0=none, 4=severe).

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026